Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
34.10B | 34.06B | 28.07B | 24.02B | 19.81B | Gross Profit |
8.44B | 8.25B | 6.72B | 5.70B | 4.89B | EBIT |
3.75B | 1.76B | 2.23B | 2.71B | 1.76B | EBITDA |
6.34B | 3.02B | 3.80B | 2.86B | 3.13B | Net Income Common Stockholders |
3.95B | 735.00M | 2.15B | 2.13B | 1.79B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.26B | 2.74B | 2.57B | 3.19B | 3.86B | Total Assets |
31.54B | 32.01B | 30.30B | 23.71B | 22.62B | Total Debt |
7.60B | 7.21B | 7.86B | 4.16B | 4.16B | Net Debt |
5.93B | 5.03B | 5.75B | 1.57B | 763.00M | Total Liabilities |
20.23B | 22.10B | 20.07B | 14.31B | 13.63B | Stockholders Equity |
10.27B | 8.85B | 8.97B | 8.47B | 8.06B |
Cash Flow | Free Cash Flow | |||
279.00M | 2.75B | 1.05B | 1.47B | 2.15B | Operating Cash Flow |
1.49B | 3.97B | 1.96B | 2.26B | 2.72B | Investing Cash Flow |
-1.78B | -1.64B | -4.17B | -873.00M | -719.00M | Financing Cash Flow |
-173.00M | -2.18B | 1.67B | -2.23B | 280.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $6.29B | 9.42 | 17.34% | 1.94% | 11.36% | 13.78% | |
74 Outperform | $126.89B | 20.72 | 27.91% | 1.25% | -20.93% | -34.33% | |
73 Outperform | $56.10B | 13.52 | 24.93% | 1.15% | -4.29% | -9.76% | |
72 Outperform | $47.41B | 12.16 | 41.27% | 2.07% | 0.14% | 444.36% | |
66 Neutral | $162.98B | 15.46 | 55.36% | 1.62% | -3.36% | 9.59% | |
64 Neutral | $2.07B | ― | -3.92% | 2.80% | -2.57% | -248.28% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% |